Skip to main content
. 2021 Mar 24;42(17):1698–1706. doi: 10.1093/eurheartj/ehab141

Figure 1.

Figure 1

Distribution of patients by the absolute change in biomarker concentrations between baseline and 12 months. One percentage of observations is truncated from each side for illustrative purposes only in this figure. GDF-15, growth differentiation factor-15; hsTnT, high-sensitivity troponin T; NT-proBNP, N-terminal pro-B-type natriuretic peptide.